Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis

The anti-IgE antibody omalizumab is currently indicated in severe asthma not controlled by standard drug therapy. Recently, new indications for omalizumab were suggested, which include atopic dermatitis (AD), a skin disorder characterized by elevated levels of IgE. We report the case of a 39-year ol...

Full description

Bibliographic Details
Main Authors: C. Incorvaia, C. Pravettoni, M. Mauro, M.-R. Yacoub, F. Tarantini, G.G. Riario-Sforza
Format: Article
Published: PAGEPress Publications 2016-01-01
Series:Monaldi Archives for Chest Disease
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/401

Similar Items